Previous 10 | Next 10 |
Someone’s sitting in the shade today because someone planted a tree a long time ago. - Warren Buffett Writing about antibiotic innovators is a quandary for me because I have to balance between the need for investment profits for investors vs. my social responsibility. It's an inte...
Outlook Therapeutics (NASDAQ: OTLK ) +26% as the company is poised to add to ONS-5010. More news on: Outlook Therapeutics, Inc., Orion Energy Systems, Inc, Sprint Corporation, Stocks on the move, Read more ...
The Medicines Company (NASDAQ: MDCO ) is up 9 % premarket, albeit on only 461 shares, in reaction to preliminary data from the ongoing Phase 2 open-label extension study, ORION-3 , evaluating twice-a-year dosing with inclisiran sodium 300 mg in patients with high cardiovascul...
This article is part of a series that provides an ongoing analysis of the changes made to David Einhorn’s Greenlight Capital 13F portfolio on a quarterly basis. It is based on Einhorn’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking David Einhorn's Greenlig...
Interim results from ongoing ORION-3 study demonstrated sustained lowering of LDL-C by more than 50 percent, with time-averaged absolute reductions of 59.4 mg/dL No material safety issues observed in the study Pivotal Phase 3 readouts for inclisiran expected in 3Q-2019 followed by ...
Noteworthy events during the week of May 12 - 18 for healthcare investors. More news on: Johnson & Johnson, Insmed Incorporated, Innovate Biopharmaceuticals, Inc., Healthcare stocks news, , Read more ...
Company management and clinical trial investigators will review interim results on the long-term safety and efficacy data of inclisiran from ongoing ORION-3 study The Medicines Company (NASDAQ:MDCO) will host a conference call and webcast for investors on Saturday, May 18, 2019, a...
The Medicines Company (NASDAQ:MDCO) announced that it will participate in the Bank of America Merrill Lynch 2019 Healthcare Conference on Tuesday, May 14, 2019, in Las Vegas. The Company is scheduled to present at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). A live audio webcast wil...
As difficult as it is to get a drug from the lab to the market, that's only part of the formula for success for biotechs - successful commercialization is every bit as important, and commercialization can have its own frustrating bumps along the road. While I see nothing wrong with the launch ...
Antibiotic resistance is a growing global public health emergency. Melinta Therapeutics ( MLNT ) has decided to take up the critical mission of overcoming antibiotic resistance with their broad spectrum antibiotic portfolio. Unfortunately, the market doesn’t see the opportunity in addre...
News, Short Squeeze, Breakout and More Instantly...
The Medicines Company Company Name:
MDCO Stock Symbol:
NASDAQ Market:
The Medicines Company Website:
The Medicines Company (the “Company”) today provided notice of a Make-Whole Fundamental Change to holders of its (i) 2.50% Convertible Senior Notes due 2022 (the “2022 Notes”), (ii) 2.75% Convertible Senior Notes due 2023 (the “2023 Notes”) and (ii) 3...
Shares of Meritor (NYSE: MTOR) , a global supplier of drivetrain, braking, and other aftermarket automotive solutions for vehicles, jumped as high as 16% Tuesday morning after markets digested the announcement that Meritor will join the S&P SmallCap 600 index. The announcement actually c...
NEW YORK , Dec. 30, 2019 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the open of trading on Monday, January 6 : NexPoint Residential Trust Inc. (NYSE: NXRT) will replace Avon Products Inc. (NYSE: AVP). Natura...